Cabozantinib Plus Ipilimumab/Nivolumab in Patients With Previously Treated Advanced Differentiated Thyroid Cancer
2024 · The Journal of Clinical Endocrinology & Metabolism · 9 citations
https://doi.org/10.1210/clinem/dgae512
D
Demond Handley
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
42
Papers
100
Citations
6
h-index
4
i10-index
Demond Handley is an academic researcher from The Ohio State University Wexner Medical Center. The author has contributed to research in topics: Global Cancer Incidence and Screening & Breast Cancer Treatment Studies & Cancer Risks and Factors. The author has an h-index of 6, co-authored 36 publications.
ORCID: 0000-0003-0223-1550Papers by this author
works997: Impact of Treatment Package Time on Survival in Adenoid Cystic Carcinoma of the Head and Neck
2024 · Radiotherapy and Oncology · 0 citations
https://doi.org/10.1016/s0167-8140(24)01486-5
Neighborhood Socioeconomic Status of Women with Locally Advanced Cervical Cancer and Access to Brachytherapy
2024 · International Journal of Radiation Oncology*Biology*Physics · 0 citations
https://doi.org/10.1016/j.ijrobp.2024.07.1564
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat